Works by Gourdin, Theodore

Results: 8

Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer.
Published in:
Prostate, 2022, v. 82, n. 13, p. 1264, doi. 10.1002/pros.24400
By:
- Bray, Alexander W.;
- Duan, Rong;
- Malalur, Pannaga;
- Drusbosky, Leylah M.;
- Gourdin, Theodore S.;
- Hill, Elizabeth G.;
- Lilly, Michael B.
Publication type:
Article
A phase I study of the ceramide nanoliposome in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 1, p. 23, doi. 10.1007/s00280-023-04588-7
By:
- Ciner, Aaron;
- Gourdin, Theodore;
- Davidson, Jeff;
- Parette, Mylisa;
- Walker, Susan J.;
- Fox, Todd E.;
- Jiang, Yixing
Publication type:
Article
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Published in:
2019
By:
- Sonpavde, Guru;
- Agarwal, Neeraj;
- Pond, Gregory Russell;
- Nagy, Rebecca J.;
- Nussenzveig, Roberto H.;
- Hahn, Andrew W.;
- Sartor, Oliver;
- Gourdin, Theodore Stewart;
- Nandagopal, Lakshminarayanan;
- Ledet, Elisa M.;
- Naik, Gurudatta;
- Armstrong, Andrew J.;
- Wang, Jue;
- Bilen, Mehmet Asim;
- Gupta, Shilpa;
- Grivas, Petros;
- Pal, Sumanta K.;
- Lanman, Richard B.;
- Talasaz, AmirAli;
- Lilly, Michael B.
Publication type:
journal article
Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.
Published in:
Asian Journal of Andrology, 2018, v. 20, n. 3, p. 1, doi. 10.4103/aja.aja_1_18
By:
- Gourdin, Theodore;
- Sonpavde, Guru
Publication type:
Article
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.
Published in:
Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1202277
By:
- Dincman, Toros A.;
- Karam, Joseph A. Q.;
- Giordano, Antonio;
- Hong Li;
- Drusbosky, Leylah M.;
- Gourdin, Theodore S.;
- Howe, Philip H.;
- Lilly, Michael B.
Publication type:
Article
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy.
Published in:
Leukemia & Lymphoma, 2014, v. 55, n. 7, p. 1533, doi. 10.3109/10428194.2013.856425
By:
- Bhatnagar, Bhavana;
- Duong, Vu H.;
- Gourdin, Theodore S.;
- Tidwell, Michael L.;
- Chen, Ching;
- Ning, Yi;
- Emadi, Ashkan;
- Sausville, Edward A.;
- Baer, Maria R.
Publication type:
Article
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075
By:
- Jun, Tomi;
- Hahn, Noah M;
- Sonpavde, Guru;
- Albany, Constantine;
- MacVicar, Gary R;
- Hauke, Ralph;
- Fleming, Mark;
- Gourdin, Theodore;
- Jana, Bagi;
- Oh, William K;
- Taik, Patricia;
- Wang, Huan;
- Varadarajan, Ajay Ramakrishnan;
- Uzilov, Andrew;
- Galsky, Matthew D
Publication type:
Article
Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials.
Published in:
Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 861, doi. 10.1177/1078155219875509
By:
- McElwee, Jessica H;
- Gourdin, Theodore S;
- Mikoll, Jennifer;
- Weeda, Erin;
- Sion, Amy M
Publication type:
Article